Related Experiment Video
Updated: Jun 17, 2026
04:08
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
[Parkinson syndromes in geriatrics]
S De Breucker1, Y P Nkodo-Mekongo, G Herzog
1Clinique de Gériatrie, Hôpital Erasme, Bruxelles.
Revue Medicale De Bruxelles
|December 17, 2009
Summary
Diagnosing Parkinson syndromes in frail elderly patients requires a specialized approach. This strategy aims to improve care plans, optimize treatment, and enhance the quality of life for geriatric patients.
Area of Science:
- Geriatrics
- Neurology
- Movement Disorders
Context:
- Geriatric teams frequently encounter patients with Parkinson syndromes.
- Patient frailty can obscure the diagnosis of Parkinson's disease and related disorders.
- A structured diagnostic approach is crucial for effective management.
Purpose:
- To propose a diagnostic strategy for Parkinson syndromes in geriatric patients.
- To facilitate early and accurate diagnosis, considering patient frailty.
- To guide the development of targeted care plans and prioritize interventions.
Summary:
- The proposed diagnostic approach involves collaboration between geriatricians, neurologists, general practitioners, and caregivers.
- It emphasizes identifying Parkinson syndromes early, even in frail individuals.
- The strategy aims to differentiate Parkinson's disease from other parkinsonian syndromes.
Impact:
- Optimizes and adapts treatment plans for geriatric patients with Parkinson syndromes.
- Helps prevent functional decline and reduces the burden on caregivers.
- Ultimately aims to improve the quality of life and end-of-life care for affected individuals.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...